Travis Dockter

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

Tanios Bekaii‐Saab, Fang‐Shu Ou, Daniel H. Ahn et al. · The Lancet Oncology · 2019 · 284 citations · Full text

Medicine, Oncology, Pharmacology +12

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Pooja Advani, Karla V. Ballman, Travis Dockter et al. · Journal of Clinical Oncology · 2015 · 168 citations · Full text

Medicine, Cardiology, Oncology +17

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

Debra L. Barton, Jeff A. Sloan, Lynne T. Shuster et al. · Supportive Care in Cancer · 2017 · 86 citations

Medicine, Gynecology, Oncology +13

North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study

Alexis D. Leal, Rui Qin, Pamela J. Atherton et al. · Cancer · 2014 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Matthew P. Goetz, Krishna R. Kalari, Vera J. Suman et al. · JNCI Journal of the National Cancer Institute · 2016 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +16